Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
- Ren G. , et al.
2. The outcomes and mechanisms of chronic hepatitis B complicated by metabolic dysfunction-associated steatotic liver disease
- Li M.P. , et al.
3. Association between hepatic steatosis and HBsAg seroclearance in patients with chronic hepatitis B: A prospective cohort study
- Fang Y. , et al.
4. Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B
- Jang T.Y. , et al.
6. Obesity management for the hepatologist - What to do, how to do it and why?
- Watt K.D. , et al.
7. Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
- Zhang S. , et al.
8. Unveiling low level viremia in chronic hepatitis B: challenges and new horizons
- Wang B. , et al.
9. Tissue-resident memory CD8+T cells might enhance HBV DNA clearance in CHB patients with MASLD complication and normal ALT via the CCL-CCR pathways
- Cai C. , et al.
10. HBV reactivation and its metabolomic profile after liver transplantation for hepatocellular carcinoma in non-alcoholic steatohepatitis
- Chen J. , et al.
11. Intrinsic Immune Response of HBV/HDV-Infected Cells and Corresponding Innate (Like) Immune Cell Activation
- Groth C. , et al.
12. Research advances in chronic hepatitis B with metabolic dysfunction-associated steatotic liver disease
- Yin K. , et al.
13. Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study
- Yi S. , et al.
14. The Association Between Weight Loss and Hepatitis B Surface Antigen Seroclearence in Chronic Hepatitis B Patients
- Tuna N. , et al.
15. Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease
- Patel N.H. , et al.
16. Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study
- Abu Baker F. , et al.
17. Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study
- Chen C.L. , et al.
18. Basic research on chronic hepatitis B virus infection and metabolic dysfunction: Advances and controversies
- Yu B. , et al.
19. Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink
- Fernandez C.J. , et al.
20. Chronic hepatitis B comorbid with nonalcoholic fatty liver disease:Contemporary insights and controversies
- Yang T. , et al.
21. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data metaanalysis
- Wong Y.J. , et al.
22. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
- Boora S. , et al.
23. Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
- Liu L. , et al.
24. Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
- Zhang S. , et al.
25. NAFLD and HBV interplay - related mechanisms underlying liver disease progression
- Tourkochristou E. , et al.